期刊文献+

尾加压素II与血管重构(英文)

Urotensin II and vascular remodeling
下载PDF
导出
摘要 血管重塑与多种临床疾病有密切关系。尾加压素II是迄今为止在哺乳动物体内发现的最强的缩血管活性肽,参与了多种心血管疾病的病理生理过程,新近研究发现它在血管重塑过程中亦发挥着重要作用。 Urotensin Ⅱ is one of the most potent vasoconstrictor known, even more potent than endothelin-1. It was first isolated from the fish umphyses and has been recognized as a hormone in the neuroseeretory system of teleost fish for over 30 years. After the identification of U-Ⅱ in humans and the orphan human G-protein-coupled receptor 14 ( GPR14 ) as U-Ⅱ receptor( UT), many studies have shown that U-Ⅱ may play an important role in cardiovascular regulation. The present review suggess that U-Ⅱ may also bring into full play in vascular remodeling. In the text, we reviewed the physiological and pathophysiological significance of U-Ⅱ in the vasculature, and focused on the correlation between U-Ⅱ and vascular remodeling.
出处 《心脏杂志》 CAS 2007年第5期606-610,共5页 Chinese Heart Journal
基金 Supported by national natural science foundation(No.30470730) Postdoctoral Science Foundation(No.2003033439)of China.
关键词 尾加压素Ⅱ 血管重构 信号转导 Urotensin Ⅱ vascular remodeling signal transduction
  • 相关文献

参考文献22

  • 1吴明,王安才.血管重构与临床[J].心脏杂志,2005,17(2):160-162. 被引量:11
  • 2Ashton N. Renal and vascular actions of urotensin Ⅱ[ J ]. K/dney lnt, 2006, 70(4) :624 -629.
  • 3Carotenuto A, Grieco P, Rovero P,et al. Urotensin-Ⅱ receptor antagonists[J]. Curr Med Chem, 2006, 13(3) :267 -275.
  • 4Grieco P, Carotenuto A, Campiglia P, et al. Urotensin-Ⅱ receptor ligands. From agonist to antagonist activity [ J ]. J Med Chem, 2005, 48(23) :7290-7297.
  • 5Lim M, Honisett S, Sparkes CD,et al. Differential effect of urotensin Ⅱ on vascular tone in normal subjects and patients with chronic heart failure [J]. Circulation, 2004, 109(10) : 1212 - 1214.
  • 6Zhu YZ, Wang ZJ, Zhu YC,et al. Urotensin Ⅱ causes fatal circulatory collapse in anesthesized monkeys in vivo: a " vasoconstrictor" with a unique hemodynamic profile [ J ]. Am J Physiol Heart Circ Physiol, 2004, 286(3): H830- H836.
  • 7Zhu YC, Zhu YZ, Moore PK. The role of urotensin Ⅱ in cardiovascular and renal physiology and diseases [ J ]. Br J Pharmacol, 2006, 148(7) :884 -901.
  • 8Lacza Z, W Busija D. Urotensin-lI is a nitric oxide-dependent vasodilator in the pial arteries of the newborn pig [ J ]. Life Sci, 2006, 78 ( 23 ) :2763 - 2766.
  • 9Hassan GS, Douglas SA, Ohlstein EH,et al. Expression of urotensin-Ⅱ in human coronary atherosclerosis J ]. Peptides, 2005, 26 (12) :2464 -2472.
  • 10Thanassoulis G, Huyhn T, Giaid A. Urotensin Ⅱ and cardiovaseular diseases[J]. Peptides, 2004, 25(10) :1789 - 1794.

二级参考文献57

  • 1Hong MK, Mintz GS, Abizaid AS, et al. Intravascular ultrasound assessment of the presence of vascular remodeling in diseased human saphenous vein bypass grafts[J]. Am J Cardiol, 1999, 84(9): 992-998.
  • 2Gonzlez MC, Arrobas SM, Molero F, et al. Effect of removal of adventitia on vascular smooth muscle contraction and relaxation [J].Am J Physiol Heart Circ Physiol , 2001,280 :H2876 - H2881.
  • 3Schulze-Bauer CAJ, Regitnig P, Hotzapfer GA. Mechanics of the human femoral adventitia including the high pressure response[J].Biomech,2002,282 (6): H2427 - H2440.
  • 4Stenmark KR, Gerssimovskaya E, Nemenoff RA, et al. Hypoxic activation of adventitial fibroblasts role in vascular remodeling [J].Chest, 2002,122:326s - 334s.
  • 5Bayer IM, Adamson SL, Langille BL. Atrophic remodeling of the artery-cuffed artery [J]. Arterioscler Thomb Vasc Biol, 1999,19(6): 1499 - 1505.
  • 6Brasunwald 陈灏珠.心脏病学[M](第5版)[M].人民卫生出版社,2000.1001-1006.
  • 7Han Y,Runge MS, Brasier AR. Angiotensin Ⅱ induces interleukin6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors [J]. Circ Res,1999,84(6) :695 -703.
  • 8Lauth M, Berger MM ,Cattarazza M, et al. Elevated perfusion pressure upragulates endothelin-1 and endothelin β receptor expression in the rabbit carotid artery[J]. Hypertension, 2000, 35 (2) :648 -654.
  • 9Schoenhangen P, Ziada KM, Vince DG, et al. Arterial remodeling and coronary artery disease:the concept of "dilated" versus "obstructive" coronary artherosclerosis[J]. J Am Coll Cardiol, 2001,38:297 - 306.
  • 10Jorgensen B, Simonsen S, Endresen K, et al. Restenosis and clinical outcome in patients treated with Amlodipine after angioplasty:results from CAPARES[J]. Am Coll Cardiol, 2000,35 ( 3 ) :592 -599.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部